Retro Biosciences
The AI engine Fit Assessment
BetaRetro Biosciences is focused on developing therapeutics that target the cellular mechanisms of aging, including cellular reprogramming and autophagy. Their mission is to enhance healthy human lifespan by addressing age-related diseases through innovative research and development.
Blurb
Retro Biosciences focuses on cellular reprogramming, autophagy, and plasma-inspired therapeutics.
HQ Location
Redwood City (United States)
Founded
2021
Employees
51 - 200
Total funding raised
$180.00M
Funding Status
Pre-Seed, $180.00M, April 6, 2022
Retro develops therapies for diseases driven by the biology of aging. We focus on cellular reprogramming and autophagy to rejuvenate cell and tissue function with the ultimate aim of adding 10 years to healthy human lifespan.